The Biotech Startups Podcast 🧬Alfredo Andere - LatchBio: Revolutionizing Biopharma Data & Mastering Enterprise Sales (Part 4/4)
Apr 10, 2025
48:45
🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.
As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.
"Focus and commitment to niche ideas have huge payoffs."
In part four of our conversation with Alfredo Andere, co-founder of LatchBio, we explore how the company evolved from a simple workflow orchestrator into a comprehensive platform serving biopharma companies and solution providers. Alfredo shares his approach to enterprise sales, emphasizing the importance of speed, focus, and building strong relationships with customers. He also delves into his philosophy on fundraising and the pivotal role of iterative development in creating impactful biotech solutions.
Alfredo reflects on the challenges and rewards of working in niche markets, explaining why deep commitment and loyalty to specific problems are essential for long-term success. Whether you’re a first-time founder or an experienced entrepreneur, this episode is packed with actionable insights on building, selling, and scaling in the biotech space.
Key topics covered:
- Iterative product development: Expanding LatchBio’s platform from workflows to data storage and analysis
- Biopharma vs. solution providers: How LatchBio serves these distinct customer groups
- Enterprise sales best practices: Qualifying leads and acting as a consultant to customer problems
- Fundraising strategies: Why early-stage rounds focus on vision and team, while later rounds prioritize traction
- The power of focus: Avoiding the trap of optionality and scaling only when ready
If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.
Subscribe to the Podcast:
Find our guest, Alfredo Andere, at these links:
Find our host, Jon Chee, at these links:
LinkedIn: https://www.linkedin.com/in/jonchee
Learn more about Excedr:
LinkedIn: https://www.linkedin.com/company/excedr/
Website: https://www.excedr.com
Intro & Outro Songs Created by OkKyojin, Owned by Excedr:
Website: https://flow.page/kyojin
Resources & Articles:
Viktor Frankl's "Man’s Search for Meaning": https://www.goodreads.com/book/show/4069.Man_s_Search_for_Meaning
Lux Capital’s Article: Why High-Throughput Bio Research Needs Better Tools: Immediately: https://www.luxcapital.com/content/why-high-throughput-bio-research-needs-better-tools-immediately
AlphaFold 2: https://alphafold.ebi.ac.uk/
Bulk RNA-seq Analysis Tools: https://en.wikipedia.org/wiki/List_of_RNA-Seq_bioinformatics_tools
Paul Graham’s "How to Raise Money": https://www.paulgraham.com/fr.html
Companies, Universities, & People mentioned:
Latch Bio: https://latch.bio
Illumina: https://illumina.com
Oxford Nanopore Technologies: https://nanoporetech.com
10x Genomics: https://10xgenomics.com
Fluent BioSciences: https://www.fluentbio.com/
Complete Genomics: https://www.completegenomics.com
Kenny Workman: https://www.linkedin.com/in/kennyworkman
Kyle Giffin: https://www.linkedin.com/in/kylegiffin
Aidan Abdulali: https://www.linkedin.com/in/aidanabdulali
Nathan Manske: https://www.linkedin.com/in/nathan-manske-0232a192/
Michael Paliotti: https://www.linkedin.com/in/michael-paliotti
Timestamps:
00:00 Intro
01:56 LatchBio’s Evolution and Iterative Development
08:20 Biopharma vs. Solution Providers
14:01 Enterprise Sales Philosophy
23:38 Fundraising Strategies and Team Building
34:59 Future Vision for LatchBio
39:36 Closing Thoughts and Shoutouts
43:46 Advice to 21-Year-Old Self
46:21 Outro
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.